William P. Mills, III

Phone212 504 6436

Peer Rating
 5.0/5.0
AV® Preeminent

Client Rating

Featured AV Peer Review Rated Lawyer IconFeatured AV Peer Review Rated Lawyer Icon
Printer Friendly VersionEmail this PageDownload to My Outlook ContactsAdd lawyer to My FavoritesCompare this lawyer to other lawyers in your favorites

Experience & Credentials Ratings & Reviews
 

Practice Areas

  • Corporate
  • Corporate Finance
  • Corporate Governance
  • Private Equity
  • Distressed Investing and Mergers & Acquisitions
  • Health Care
  • Mergers & Acquisitions
 
Contact InfoTelephone: 212 504 6436
Fax: 212 504 6666
http://www.cadwalader.com/professionals/william-mills
 
University Georgetown University, A.B., cum laude, 1988
 
Law SchoolFordham University, School of Law, J.D., 1991
 
Admitted1991, Connecticut; 1992, New York; U.S. District Court, Southern District of New York
 
Memberships V2N1 Mar 26, 2014

Videos

• Cadwalader is a Leading Advisor to Corporations and Financial Institutions Sep 18, 2013

 
Biography

William Mills concentrates his practice in the area of corporate law, with emphasis on mergers and acquisitions, securities law, corporate finance and corporate governance. Bill represents clients in a wide range of complex transactions, including mergers, acquisitions, divestitures, public and private securities offerings, proxy contests, spin-offs, restructurings, leveraged buyouts, tender offers, exchange offers, and joint ventures. He also represents investment banks as financial advisers on M&A and other transactions. Bill advises listed public companies in the areas of corporate governance, crisis management, executive compensation, contractual negotiations, and general regulatory compliance.

He received his A.B., cum laude, from Georgetown University and his J.D. from Fordham Law School where he was Notes and Comments Editor of the International Law Journal.

News Releases

• Cadwalader Recognized Among Leading Law Firms in 2015 Edition of IFLR 1000 Oct 21, 2014

• Cadwalader Advises Forbes Media LLC on Majority Stake Sale to International Investors Jul 18, 2014

• Cadwalader Recognized Among Leading Firms in The Legal 500 US 2014 Jun 27, 2014

• Cadwalader Again Recognized Among Legal Leaders by IFLR 1000 Nov 15, 2013

• Cadwalader Recognized in 2013 Edition of The Legal 500 US Oct 25, 2013

• IFLR 1000 Again Names Cadwalader a Leader in Core Transactional Areas of Practice Nov 06, 2012

• The Legal 500 Recognizes More than 15 Cadwalader Practices and 47 of the Firm's Lawyers Across U.S. Offices Jun 06, 2012

• Cadwalader Advises on Transaction Shortlisted for M&A Advisor Magnus Award for Deal of the Year Nov 16, 2011

• IFLR 1000 Again Names Cadwalader a Leader in Core Transactional Areas of Practice Oct 19, 2011

• Cadwalader Named to Winner's Circle at M&A Atlas Awards Feb 24, 2010

• Cadwalader Transaction Named IDD Deal of the Year Feb 12, 2010

Recent Press

• Cadwalader, Simpson Thacher, White & Case on $2.38B KKR-Pfizer Deal Apr 04, 2011

• Cadwalader, Covington Handle Pfizer's King Pharmaceuticals Buy Oct 12, 2010

• New Deals - Lawyers on Major Transactions Jan 29, 2009

• A Long Weekend for Cadwalader, Simpson and Wachtell Jan 26, 2009

Recognition

• Cadwalader Recognized Among Leading Law Firms in 2015 Edition of IFLR 1000 Oct 21, 2014

• Cadwalader Recognized Among Leading Firms in The Legal 500 US 2014 Jun 27, 2014

• Cadwalader Again Recognized Among Legal Leaders by IFLR 1000 Nov 15, 2013

• Cadwalader Recognized in 2013 Edition of The Legal 500 US Oct 25, 2013

• International Financial Law Review's 2013 IFLR 1000 Nov 06, 2012

• 2012 Legal 500 US Jun 06, 2012

Clients & Friends Memos

• M&A Update: Federal Court Decision in Allergan Control Battle Raises Serious Questions for New Takeover Technique Nov 06, 2014

• M&A Update: No Control, No Conflict, No Problem Oct 31, 2014

• M&A Update: Chancery Court Orders Financial Advisor to Pay Millions in Damages For Aiding and Abetting Breach of Fiduciary Duty Oct 13, 2014

• M&A Update: Delaware Court Upholds Sotheby's Poison Pill Defense Against Activist Citing “Negative Control” as a Corporate Threat May 05, 2014

• M&A Update: Chancery Court Provides Another Lesson for a Reasonable Sale Process Apr 30, 2014

• M&A Update: Ohio Federal Judge Blocks Controlling Stockholder's Tender Offer Based On Target Board's Conflicts and Stockholder Coercion Apr 17, 2014

• M&A Update: Delaware Court's Orchard Enterprises Decision Provides Key Insights For Special Committees In Controlling Stockholder Transactions Mar 19, 2014

• M&A Update: Delaware Supreme Court Upholds Business Judgment Rule Review for Certain Controlling Stockholder Transactions with Dual Minority Protections Mar 17, 2014

• M&A Update: The “Gatekeepers”: Delaware Court Holds Conflicted Financial Advisor Liable for Aiding and Abetting Breach of Fiduciary Duty Mar 13, 2014

• M&A Update: Delaware Court Allows Claims for Breach of Implied Good Faith Covenant in Earn-Out Case Feb 19, 2014

• M&A Update: Highlights from 2013 and Implications for 2014 Jan 17, 2014

• Chancery Court Takes Firm Stance on Seller's Pre-Closing Privileged Communication Nov 22, 2013

• Delaware Court Confirms High Bar To Escape Deal Nov 14, 2013

• Recent Amendments to Rule 14a-8 and the Implications for the 2012 Proxy Season Sep 28, 2011

Events

• Financial Advisor Conflicts of Interest Jun 05, 2014

• Tulane Corporate Law Institute Mar 27, 2014

Experience
•Forbes Media LLC on its pending sale of a majority stake to a group of international investors as part of the Company's global growth strategy.
•Towers Watson's acquisition of Extend Health
•AngioDynamics' acquisitions of Navilyst Medical, Microsulis Medical, Vortex Medical and Clinical Data
•Elan Corporation's $3.25 billion sale of Tysabri rights to Biogen Idec
•U.S. Treasury's $250 billion TARP Capital Purchase Program
•Pfizer Inc.'s sale of its Capsugel business to KKR
•DPL Inc.'s merger with AES Corp.
•Pfizer Inc.'s acquisition of King Pharmaceuticals
•Bear Stearns Companies Inc. acquisition by JPMorgan Chase
•Pfizer Inc.'s acquisition of Wyeth
•Trian Fund Management in the sale of Wendy's International to Triarc Companies
•Pfizer Inc.'s $16 billion sale of its consumer health care division to Johnson & Johnson
•Xstrata Plc's sale of its Noranda aluminum division to Apollo Management
•Trian Partners' successful proxy contest with H.J. Heinz Company
•StorageTek's merger with Sun Microsystems
•Pfizer Inc.'s acquisitions of Vicuron Pharmaceuticals and Embrex Inc.
•Celanese's sale of its polyvinyl alcohol business to Sekisui Chemical
•RGIS Holdings' sale to the Blackstone Group
•Republic Bancorp Inc.'s merger with Citizens Banking Corporation
•Pfizer Inc.'s acquisition of Warner-Lambert
•U S WEST's merger with Qwest Communications
•MediaOne's merger with AT&T
•Dayton Power & Light's $850 million sale of its private equity portfolio
•Six Flags Inc.'s joint venture to acquire Dick Clark Productions Inc.
•Credit Suisse's acquisitions of Select Portfolio Servicing and Lime Financial
•Del Laboratories' sale to Kelso & Company
•Dianon Systems' sale to Laboratory Corporation of America
•Bear Stearns' acquisition of United Companies Financial Corp.
•Toys R Us, Inc.'s joint venture with Softbank Capital Partners
•Bally Total Fitness' acquisition of Crunch Fitness International
•Dianon Systems' acquisition of UroCor, Inc.
•Moore Medical Corp.'s acquisition by McKesson Corporation
•Six Flags Inc.'s sale of theme parks to Parc 7F- Operations and CNL Income Properties
•ShopRite Supermarkets' acquisition of Big V Supermarkets
•Toysrus.com's joint venture with Amazon.com

As counsel to financial advisors:

•Dell Inc.'s $24 billion going private transaction with Michael Dell and Silver Lake Partners
•Par Pharmaceutical's $1.9 billion sale to TPG
•Cytec's sale of its coating resins business to Advent International
•CVS's $27 billion merger with Caremark
•Cedar Fair's acquisition of Paramount Parks
•The Walt Disney Company's acquisition of Pixar
•Sotheby's Holdings Inc.'s recapitalization transaction with A. Alfred Taubman
•Google Inc.'s investment and strategic alliance with America Online, Inc.
•Harrahs Entertainment's acquisition of Rio Hotel & Casino, Inc.
•Symbion's acquisition by Crestview Partners
•Carreker's acquisition by Checkfree Corporation
•Shire plc's acquisition of New River Pharmaceuticals
•Primedex Health Systems merger with Radiologix, Inc.
•ADVO Inc.'s merger with Valassis Communications
•Caxton-Iseman Capital, Inc.'s acquisition of Valley National Gases Incorporated
•St. Jude Medical, Inc.'s acquisition of Advanced Neuromodulation Systems, Inc.

Securities offerings by:

•Pfizer Inc.
•Elan Corporation
•The Bear Stearns Companies Inc.
•The Dayton Power & Light Company
•Northwest Airline Corporation
•Cosi, Inc.
•Scientific Games Corporation

Newsletter

Quorum

• Quorum: March 2014

 
ISLN900968431
 

Documents by this lawyer on Martindale.com

Subscribe to this feed

Federal Court Decision in Allergan Control Battle Raises Serious Questions for New Takeover Technique
Joshua Apfelroth,Gregory A. Markel,William P. Mills,Martin L. Seidel, November 15, 2014
The Federal District Court’s November 4th ruling in Allergan, Inc. vs. Valeant Pharmaceuticals International, Inc. raises “serious questions” for the takeover partnership employed by Valeant and Pershing Square in their hostile bid to acquire Allergan.

No Control, No Conflict, No Problem
Joshua Apfelroth,Gregory A. Markel,William P. Mills,Martin L. Seidel, November 15, 2014
On October 24th, the Delaware Chancery Court dismissed a lawsuit challenging the merger of Crimson Exploration and Contango Oil & Gas. Minority Crimson stockholders alleged that Oaktree Capital Management, Crimson’s largest stockholder with a 33.7% stake, controlled Crimson and caused it...

M&A Update: Chancery Court Orders Financial Advisor to Pay Millions in Damages For Aiding and Abetting Breach of Fiduciary Duty
Gregory A. Markel,William P. Mills,Martin L. Seidel, October 22, 2014
On October 10, 2014, Vice Chancellor Travis Laster ruled that RBC Capital was liable to the former stockholders of Rural/Metro Corporation for $75.8 million - representing 83% of the total damages - for aiding and abetting breaches of the duty of care by Rural/Metro’s board in connection with...



View Ratings & Reviews
Profile Visibility
#9,629 in weekly profile views out of 95,369 lawyers in New York, New York
#132,239 in weekly profile views out of 1,585,416 total lawyers Overall

Office Information

William P. Mills, III


New YorkNY 10281-0006




Loading...
 

Professional Networking for Legal Professionals Only

Quickly and easily expand your professional
network - join the premier global network for legal professionals only. It's powered by the
Martindale-Hubbell database - over 1,000,000 lawyers strong.
Join Now